Immunity to Taiwan Taenia infection in pigs can be stimulated using homologous or heterologous nonviable Taenia oncospheres. This study was designed to determine whether homologous non-viable oncospheres could stimulate immunity to Hymenolepis infection in rodents. Hatched oncospheres were prepared from eggs of Hymenolepis diminuta, Hymenolepis nana, and Hymenolepis microstoma and kept at -70°C for more than 1 month. A mixture of 500 non-viable oncospheres of each tapeworm and complete Freund's adjuvant was injected subcutaneously in four groups of Sprague-Dawley rats or ICR mice one to four times at an interval of 1 week; controls were not immunized. After immunization, each rodent was orally inoculated with three fresh active cysticercoids of H. diminuta or H. microstoma or 500 fresh eggs of H. nana. The animals were then necropsied for adult tapeworms. No rats or mice immunized with non-viable oncospheres of H. diminuta or H. nana were infected by the challenge inoculation. However, 28 of 34 mice immunized with non-viable H. microstoma oncospheres were infected after inoculation with cysticercoids. This study demonstrated complete protection against infection by homologous parasites in rats or mice immunized with non-viable oncospheres of H. diminuta and H. nana, respectively. Repeated immunization may not be required if resistance is stimulated in rodent hosts.
A single oncosphere of Hymenolepis nana in the intestinal villus can elicit complete protection against subsequent egg challenge in mice within 2 days [1] [2] [3] . Moreover, mice initially infected with H. nana eggs become completely resistant to challenge with mouse-derived cysticercoids after more than 10 days [4] . Although no worm expulsions or worm senescence of Hymenolepis diminuta occurs throughout the life span of the rat host when about 10 or fewer worms are initially established [5] [6] [7] , immunologically mediated rejection of this parasite by the rat have been reported [8] . Mice infected with Hymenolepis microstoma have also been reported to be resistant to reinfection [9] . These findings suggest that mice and rats could be immunized using vaccines against Hymenolepis species. Recently, we succeeded in showing cross-protection against Taenia taeniaformis in rats immunized with nonviable oncospheres of Asian Taenia or Taenia saginata [10] . Immunity to Taiwan Taenia infection in pigs can also be stimulated using homologous or heterologous non-viable oncospheres of Taenia species (Fan et al, unpublished data). It is worth investigating whether homologous non-viable oncospheres can stimulate immunity to Hymenolepis infection in rodents.
MATERIALS AND METHODS

Preparation of vaccines
Eggs of H. diminuta, H. nana, and H. microstoma were prepared from the gravid proglottids of tapeworms established in mice or rats in our laboratory [11] . The oncospheres were hatched and activated in vitro using the method described by Stevenson [12] . These hatched oncospheres were then suspended in Eppendorf tubes containing sterile phosphatebuffered saline (PBS) and immediately stored at -70°C for more than 1 month before use.
Immunization
For experiments with H. diminuta, 15 male Sprague-Dawley rats (150 g) were divided into five groups, four experimental groups and a control group. A mixture of 500 non-viable H. diminuta oncospheres (0.2 mL) and 0.2 mL complete Freund's adjuvant (CFA) was injected subcutaneously, once in the first group, twice in the second group, three times in the third group, and four times in the fourth group. The interval between successive immunizations was 1 week. In the control group, rats were injected subcutaneously with a mixture of PBS (0.2 mL) and CFA (0.2 mL).
For experiments with H. nana and H. microstoma, 25 male ICR mice (25 g) were used for each species, divided into five groups. A mixture of 500 non-viable oncospheres (0.2 mL) and 0.2 mL CFA was injected subcutaneously, once in the first group, twice in the second group, three times in the third group, and four times in the fourth group. The interval between successive immunizations was 1 week. In the fifth, control, group, mice were injected subcutaneously with a mixture of PBS (0.2 mL) and CFA (0.2 mL).
Experimental infection, sacrifice, and examination
Rats were challenged with H. diminuta by oral inoculation with three fresh active cysticercoids 24 days after the last immunization and were sacrificed 28 days after infection. Mice were challenged with H. nana by oral inoculation with 500 fresh eggs 24 days after the last immunization and were killed on day 22 after infection. Mice were challenged with H. microstoma by oral inoculation with three fresh active cysticercoids 24 or 34 days after the last immunization. These mice were sacrificed on day 26 or day 13, respectively, after infection. The methods used for experimental infection, examination for adult worms and determination of developmental stage have been described in our previous study [11] .
RESULTS
In the four control groups, four to 12 worms were found. No rats or mice immunized with non-viable H. diminuta or H. nana oncospheres were infected by the challenge organism (Tables 1 and 2 ). However, 30 of 40 mice immunized with non-viable H. microstoma oncospheres were infected on day 13 or day 26 after oral inoculation. From each experimental group, three to 12 worms were recovered. All six mice in the control groups were infected and 16 worms were recovered (Table 3 ).
DISCUSSION
Subcutaneous injection of a crude homogenate of mature worms of H. nana with CFA or aluminum hydroxide evokes protection against egg challenge in immunized mice [13, 14] . Larsh reported a 75% reduction in cysticercoids recovered from immunized mice [13] . Coleman et al obtained more effective results, as indicated by almost complete failure of adult recovery [14] . In the present study, we demonstrated complete protection against infection by homologous parasites in rats or mice immunized with nonviable H. diminuta and H. nana oncospheres. Mammalian intermediate hosts for larval cestodes have complete resistance to re-infection even with a single oncosphere [15] . In the present study, subcutaneous immunization with non-viable oncospheres also conferred protection on the definitive mammalian hosts of cestodes. Stimulation of complete resistance against H. diminuta and H. nana cysticercoids required one immunization with nonviable oncospheres. Repeated immunizations were not required.
We obtained very good results in rats or mice immunized with non-viable homologous H. diminuta or H. nana oncospheres. However, mice infected with H. microstoma were found in all four experimental groups after immunization with non-viable homologous oncospheres. Mice show a high level of resistance to challenge with H. nana cysticercoids only in the prepatent period, while mice that have been infected or in the patent period are highly resistant to both cysticercoids and oncospheres of H. nana [16] . Moreover, specific antibodies against oncosphere antigens have been demonstrated in mice with patent infection [17] . It is possible that inoculation with non-viable oncospheres may stimulate stage-specific immunity, which may not protect mice from infection by homologous cysticercoids. However, further studies are required to clarify this suggestion.
